We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Gene therapy spinout Nightstar Therapeutics signs deal with Oxford University Innovation to tackle Stargardt disease.
Oxford University Innovation’s digital health deal with Drayson Technologies and Oxford University Hospitals celebrated at annual OBN awards.
In Q2 2017, Oxford companies raised £93m, OUI was named TTO of the Year, and the £1.2bn contribution to the global economy from Oxford's commercialisation capabilities was highlighted in a new report.
The Oxford University AI company secures £17m as it unveils three AI-driven platforms.
The Oxford University company secures £2.3m in Series A funding to translate image management platform for the consumer market.
Scenic Biotech’s ‘genetic off-switch’ for disease secures major investment to accelerate development
Scenic Biotech, an international collaboration between Oxford University and Netherlands Cancer Institute, aims to unlock genetic potential in tackling cancer and other diseases with new funding.